10x Genomics, Inc. (TXG) /

The profitability of 10x Genomics, Inc. over the past 9 years

Chart 10x Genomics, Inc.: gross profit, operating income, net income, fiscal 2017–2025 Open the chart →

10x Genomics, Inc. reported a net loss of $43.54M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $443.88M and an operating loss of $60.98M. It reported a loss in all 9 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$443.88M-$60.98M-$43.54M
2024ended Dec 31, 2024$414.48M-$194.56M-$182.63M
2023ended Dec 31, 2023$409.31M-$265.33M-$255.1M
2022ended Dec 31, 2022$396.02M-$167.94M-$166M
2021ended Dec 31, 2021$416.4M-$52.25M-$58.22M
2020ended Dec 31, 2020$240.38M-$534.14M-$542.73M
2019ended Dec 31, 2019$184.86M-$30.57M-$31.25M
2018ended Dec 31, 2018$117.65M-$110.76M-$112.48M
2017ended Dec 31, 2017$60.52M-$18.38M-$18.76M

Fiscal years as 10x Genomics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on 10x Genomics, Inc.

Companies of a similar size

Not investment advice. This page shows what 10x Genomics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.